tiprankstipranks
Trending News
More News >
MaaT Pharma (FR:MAAT)
:MAAT
France Market
Advertisement

MaaT Pharma (MAAT) Technical Analysis

Compare
3 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
4Bullish
3Neutral
15Bearish
Technical Analysis Consensus
Neutral
4Bullish
3Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
MaaT Pharma’s (MAAT) Moving Averages Convergence Divergence (MACD) indicator is -0.24, suggesting MaaT Pharma is a Sell.
MaaT Pharma’s (MAAT) 20-Day exponential moving average is 4.21, while MaaT Pharma’s (MAAT) share price is €3.84, making it a Sell.
MaaT Pharma’s (MAAT) 50-Day exponential moving average is 4.59, while MaaT Pharma’s (MAAT) share price is €3.84, making it a Sell.

MaaT Pharma (MAAT) Pivot Points

Sep 29, 2025, 02:51 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.38
3.62
3.77
4.01
4.16
4.40
4.55
Fibonacci
3.62
3.77
3.86
4.01
4.16
4.25
4.40
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MaaT Pharma (MAAT) Moving Averages

Sep 29, 2025, 02:51 AM
Period
Simple
Exponential
MA5
3.99Sell
3.97Sell
MA10
4.06Sell
4.04Sell
MA20
4.08Sell
4.21Sell
MA50
4.79Sell
4.59Sell
MA100
4.90Sell
4.98Sell
MA200
5.88Sell
5.83Sell
MaaT Pharma’s (MAAT) 10-Day exponential moving average is 4.04, while MaaT Pharma’s (MAAT) share price is €3.84, making it a Sell.
MaaT Pharma’s (MAAT) 100-Day exponential moving average is 4.98, while MaaT Pharma’s (MAAT) share price is €3.84, making it a Sell.
MaaT Pharma’s (MAAT) stock price is €3.84 and MaaT Pharma’s (MAAT) 50-day simple moving average is 4.79, creating a Sell signal.
MaaT Pharma’s (MAAT) stock price is €3.84 and MaaT Pharma’s (MAAT) 100-day simple moving average is 4.90, creating a Sell signal.
MaaT Pharma’s (MAAT) stock price is €3.84 and MaaT Pharma’s (MAAT) 200-day simple moving average is 5.88, creating a Sell signal.

MaaT Pharma (MAAT) Technical Indicators

Sep 29, 2025, 02:51 AM
Name
Value
Implied Action
RSI (14)
38.39
Neutral
STOCH (9,6)
12.88
Buy
STOCHRSI (14)
27.96
Neutral
MACD (12,26)
-0.24
Sell
ADX (14)
16.88
Buy
Williams %R
-81.45
Buy
CCI (14)
-109.78
Buy
ATR (14)
0.38
-
Ultimate Oscillator
37.00
Neutral
ROC
-1.29
Sell
MaaT Pharma’s (MAAT) Relative Strength Index (RSI) is 38.39, creating a Neutral signal.
MaaT Pharma’s (MAAT) Trend Strength Indicator (ADX) is 16.88, creating a Buy signal.
MaaT Pharma’s (MAAT) Commodity Channel Index (CCI) is -109.78, creating a Buy signal.
MaaT Pharma’s (MAAT) Price Rate of Change (ROC) is -1.29, creating a Sell signal.

FAQ

Is MAAT a Buy, Hold, or Sell?
Based on MAAT’s technical indicators, MAAT is a Strong Sell.
    What is MAAT’s RSI (14)?
    MAAT’s RSI (14) is 38.39, which suggests MAAT is a Neutral.
      What is MAAT’s MACD?
      MAAT’s MACD is -0.24, which suggests MAAT is a Sell.
        What is MAAT’s 5-day moving average?
        MAAT’s 5-day moving average is 3.99, which suggests MAAT is a Sell.
          What is MAAT’s 20-day moving average?
          MAAT 20-day moving average is 4.08, which suggests MAAT is a Sell.
            What is MAAT’s 50-day moving average?
            MAAT’s 50-day moving average is 4.79, which suggests MAAT is a Sell.
              What is MAAT’s 200-day moving average?
              MAAT’s 200-day moving average is 5.88, which suggests MAAT is a Sell.
                What is MAAT’s Williams % R (14)?
                MAAT’s Williams % R (14) is -81.45, which suggests MAAT is a Buy.
                  What is MAAT’s CCI (14)?
                  MAAT’s CCI (14) is -109.78, which suggests MAAT is a Buy.
                    What is the share price of MaaT Pharma?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis